CM
CM Management’s Cytosorbents Corp CTSO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.6M | Buy |
1,250,000
+295,924
| +31% | +$379K | 1.46% | 28 |
|
2025
Q1 | $954K | Buy |
954,076
+254,076
| +36% | +$254K | 0.96% | 38 |
|
2024
Q4 | $637K | Sell |
700,000
-100,000
| -13% | -$91K | 0.57% | 48 |
|
2024
Q3 | $1.2M | Sell |
800,000
-50,000
| -6% | -$75K | 0.96% | 41 |
|
2024
Q2 | $598K | Buy |
850,000
+25,000
| +3% | +$17.6K | 0.55% | 50 |
|
2024
Q1 | $784K | Buy |
825,000
+410,000
| +99% | +$390K | 0.66% | 48 |
|
2023
Q4 | $461K | Sell |
415,000
-35,000
| -8% | -$38.9K | 0.37% | 59 |
|
2023
Q3 | $846K | Hold |
450,000
| – | – | 0.9% | 38 |
|
2023
Q2 | $1.62M | Hold |
450,000
| – | – | 1.58% | 20 |
|
2023
Q1 | $1.52M | Sell |
450,000
-25,000
| -5% | -$84.3K | 1.8% | 17 |
|
2022
Q4 | $736K | Sell |
475,000
-200,000
| -30% | -$310K | 0.88% | 36 |
|
2022
Q3 | $918K | Buy |
675,000
+75,000
| +13% | +$102K | 1.02% | 36 |
|
2022
Q2 | $1.31M | Buy |
600,000
+250,000
| +71% | +$548K | 1.4% | 28 |
|
2022
Q1 | $1.12M | Buy |
350,000
+50,000
| +17% | +$160K | 0.94% | 38 |
|
2021
Q4 | $1.26M | Buy |
300,000
+125,000
| +71% | +$524K | 0.95% | 33 |
|
2021
Q3 | $1.42M | Buy |
175,000
+25,000
| +17% | +$203K | 1.06% | 32 |
|
2021
Q2 | $1.13M | Buy |
150,000
+30,000
| +25% | +$227K | 0.82% | 46 |
|
2021
Q1 | $1.04M | Buy |
+120,000
| New | +$1.04M | 0.77% | 55 |
|